Bingham Private Wealth LLC purchased a new stake in shares of Relx Plc (NYSE:RELX – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,050 shares of the technology company’s stock, valued at approximately $220,000.
Other hedge funds have also modified their holdings of the company. Larson Financial Group LLC lifted its position in shares of Relx by 612.5% during the first quarter. Larson Financial Group LLC now owns 513 shares of the technology company’s stock valued at $26,000 after buying an additional 441 shares during the last quarter. WPG Advisers LLC purchased a new stake in shares of Relx during the first quarter valued at about $28,000. Golden State Wealth Management LLC lifted its position in shares of Relx by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company’s stock valued at $30,000 after buying an additional 294 shares during the last quarter. Cornerstone Planning Group LLC lifted its position in shares of Relx by 325.2% during the first quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company’s stock valued at $37,000 after buying an additional 530 shares during the last quarter. Finally, Ameritas Advisory Services LLC purchased a new stake in shares of Relx during the second quarter valued at about $64,000. 15.02% of the stock is owned by hedge funds and other institutional investors.
Relx Stock Performance
Shares of Relx stock opened at $46.40 on Tuesday. The firm has a market capitalization of $85.04 billion, a P/E ratio of 24.95, a PEG ratio of 3.03 and a beta of 0.87. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55. The company has a 50 day moving average price of $47.74 and a 200 day moving average price of $50.95. Relx Plc has a 52 week low of $44.19 and a 52 week high of $56.33.
Relx Cuts Dividend
Wall Street Analyst Weigh In
Several analysts have commented on the stock. Kepler Capital Markets raised shares of Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Morgan Stanley reissued an “overweight” rating on shares of Relx in a research report on Thursday, September 11th. Weiss Ratings reissued a “buy (b)” rating on shares of Relx in a research report on Saturday, September 27th. Finally, Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the stock. Based on data from MarketBeat.com, Relx has an average rating of “Buy”.
Check Out Our Latest Research Report on RELX
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Five stocks we like better than Relx
- Where to Find Earnings Call Transcripts
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- The Risks of Owning Bonds
- 3 Exceptional Stocks to Build Long-Term Wealth
- How to trade using analyst ratings
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.